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Abstract
Human B lymphocytes not only play a critical role in the humoral immunity to generate
antibodies, but also are equally important to cellular immunity as B lymphocytes can
present antigens to T lymphocytes and can release a range of potential immune-regulating
cytokines after stimulations. Human immunoglobulin class switch recombination (CSR) in
activated B cells is an essential process in the humoral immunity and the process is compli-
cated and tightly controlled bymany regulators. The recent genomic and genetic approaches
in CSR identified novel genes that were actively involved in the process. Understanding the
roles of the novel genes in CSR will bring new insights into the mechanisms of the process
and new potential therapeutic targets for immunoglobulin-related disorders such as allergic
asthma and autoimmune diseases.
Keywords: B cells, immunoglobulin class switch recombination, gene expression,
regulation
1. Introduction
Human lymphocytes include T lymphocytes, B lymphocytes and natural killer cells. T lym-
phocytes are majorly responsible for cell-mediated immunity. B lymphocytes (cells) play the
critical roles in the humoral immunity to activate immune system by secreting antibodies. B
lymphocytes are also equally critical to cellular immunity as they can also present antigens to T
lymphocytes and can also release a range of potential immune-regulating cytokines [1, 2].
The “B” from B cells came from the name of the bursa of Fabricius, a lymphoid organ in birds,
where B cells mature. It was first discovered by Chang and Glick [3]. B cells mature in the bone
marrow in mammals. B cells express B cell receptors (BCRs) on their cell membrane and BCRs
allow the cell to bind to a specific antigen and initiate an antibody response. Each B cell carries
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a unique receptor for antigen that is composed of the membrane-band form of its antibody.
After antigen recognition by the membrane-bound receptor, the B cells can proliferate to
increase their numbers and differentiate to secrete their antigen-specific antibodies.
There are three principle classes of B cells in humans according to their ontogeny and anatomic
localization: B1 cells arise from fetal liver precursors and are enriched in mucosal tissues and the
pleural and peritoneal cavities. B2 cells arise from bone marrow–derived precursors and are
enriched in secondary lymphoid organs [4]. Marginal zone (MZ) and follicular (FO) B cells are
differentiated from B2 cells in human spleen and lymph nodes [2]. B cells of each linage have
distinct and overlapping functions in recognizing antigens via T-independent and T-dependent
pathways to produce rapid IgM or long-lasting IgG antibody response [2]. Cytokines play a key
role in the commitment of naïve B cells to B effector 1 (Be-1) and B effector 2 (Be-2) lineage. Be-2
differentiation is dependent on the engagement of IL4α on B cells [5], while Be-1 cell develop-
ment is dependent on the activation of the transcription factor T-bet and the IFNγR on B cells [6].
The process of human B cell development is very complicated and is controlled by many tran-
scription factors [7]. Human B cells are generated in bone marrow from progenitor cells that are
committed to the B cell linages (pro-B cells). Each pro-B cell undergoes independent
rearrangement of diverse variable (V), diversity (D) and joining (J) gene segments of the immuno-
globulin heavy (H)-chain locus [8]. Rearrangement of the H-chain locus creates in each B cell a
variable exon with a unique upstream of the immunoglobulin constant region exons and drives
the expression of H-chain protein and then proliferate and differentiate to commence immuno-
globulin light (L)-chain gene recombination.When a B cell expresses L-chain protein, it pairs with
the previously arranged H chain and is expressed as membrane immunoglobulin on the cell
surface [9]. Human immune system can generate a diversity of specific antibodies in response to
antigen stimulation. This process is of fundamental importance to acquired immunity. The human
constant H-chain genes are on chromosome 14 containing Cμ, Cδ and two repeated clusters each
having two Cγ genes and Cε genes (Cγ3, Cγ1, pseudo-ε, Cα1 and Cγ2, Cγ4, Cε, Cα2).
In this chapter, I will briefly introduce the roles of germinal centers (GCs) and the steps of
immunoglobulin class switch recombination (CSR) in human B cells in GCs. I will discuss the
potential functional roles of the newly identified genes from the results of our experiments for
global transcript profiling in CSR. I will also discuss the future direction of the researches on
CSR in human B cells.
2. Germinal centers and immunoglobulin CSR
Germinal centers (GCs) are the sites within secondary lymphoid organs such as lymph nodes
and the spleen where mature B cells can proliferate, differentiate and mutate their antibody
genes and switch the class of their antibodies (e.g., from IgM to IgE) during a normal immune
response to antigens [10]. In the GCs, naïve B cells can have clonal expansion, somatic
hypermutation, affinity maturation, development of B cell memory and long-life plasma cells
[11–13]. B cell activation is initiated in the follicle in GCs when it encounters specific antigen
[14], and then the B cells are relocated to the periphery of the follicle [15]. The inter-follicular
zone in GCs is the site where B cell and T follicular helper cell differential initiates [16]. They
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develop dynamically after the activation of follicular B cells by T-dependent antigen. B cells in
GCs proliferate and can class-switch the BCR constant region from IgM/IgD to IgG, IgA and
IgE (discussed later). Additionally, the IgV region genes of B cells in GCs can undergo somatic
hypermutation to change the affinity of the encoded BCR for its cognate antigens, allowing
subsequent antigen-driven selection and clonal expansion of high-affinity B cells [17]. Human
B cells in GCs, in vitro–activated naïve B cells, and those with specific and rapid recall
responses to previously encountered antigen express cell-surface CD27. B cells with CD27
expression correlated with greater cell sizes, proliferative capacity, antigen presentation capac-
ity and differentiation into antibody secreting cells [18–20].
In order to generate antibodies, two somatic DNA recombination events of the genetic elements
take place in B cells. Firstly, V(D)J recombination generates the functional variable regions of the
Ig heavy-chain (IgH) and light-chain genes. Initiation of V(D)J recombination requires the
products of recombination activating genes (RAG) 1 and 2 [21, 22]. Lymphoid-specific expres-
sion of RAG 1 and 2 limits V(D)J recombination to B and T lymphocytes. Following activation,
mature B cells can undergo CSR, linking the IgH variable regions with one of the downstream
CH genes, changing the effector function of the antibody [23]. CSR and the other main diversifi-
cation event, somatic hypermutation (SHM), are both dependent on activation-induced cytidine
deaminase (AID), a protein expressed only in activated germinal center B cells [24]. The basic
steps of CSR include creating double-strand DNA breaks (DSBs) for CSR and joining donor and
acceptor S regions. Class switch recombination occurs between switch (S) regions located
upstream of each of the CH regions except Cδ and results in a change from IgM and IgD
expression in naïve B cells to express one of the downstream isotypes such as IgG subclasses,
IgA and IgE. AID plays a critical role in the vertebrate adaptive immune response [24, 25]. It
initiates the conversion of several dC bases to dU bases in each S region, dU bases are then
excised by uracil DNA glycosylase (UNG), and the resulting abasic sites are nicked by apurinic/
apyrimidic endonuclease (APE), creating single strand breaks (SSBs), that can spontaneously
formDSBs if theyare near each other on oppositeDNAstrands.After formation of theDSB in the
donor and acceptor S regions, the S regions are recombined by ubiquitous proteins that perform
nonhomologous end-joining (NHEJ) [26]. VDJ recombination and early B cell development
takes place in the bone morrow. Immature B cells expressing IgM on the surface migrate to
peripheral lymphoid tissue in the spleen, lymph nodes and gut-associated lymphoid tissue.
CSR and SHM happen in the germinal centers of secondary lymphoid tissues but also in
germinal center–like structures in local (nonlymphoid) tissues [27]. CSR is induced by both T
lymphocyte–dependent (TD) antigens and T lymphocyte–independent (TI) antigens. TD anti-
gen stimulation can be mimicked in vitro by culturing B cells in the presence of anti-CD40
antibodies along with specific cytokines. IL-4 and anti-CD40 induce isotype switching to IgG1
and IgE [28]. Chromatin structure also contributes to the regulation of CSR. Ig heavy-chain
constant genes and 3-regulatory regions are in an active chromatin conformation (acetylated
H3 and H4 and lysine 4 trimethylation H3) in unstimulated human B cells, and these modifica-
tions can spread to the S region after cytokine stimulation [29]. AID is exclusively expressed in
the germinal centers [21]. The basic AID-mediated mechanisms of CSR are quite well studied
and defined, but the global regulation of the CSR, accompanying networks of AID and other
well-known regulators, remains relatively unclear.
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3. The global gene regulation of CSR in human B cells
In vitro, IL4 and anti-CD40 signals can mimic signals from T cell in GCs to induce a strong
activation of NF-κB leading human B cells to a proliferative burst and CSR to IgE and IgG [30].
These costimulation signals were applied in the naïve B cells isolated from healthy tonsils and
profiled the transcripts at 6 time points for 12 days (0, 12, 36, 72, 120 and 288 h). More than one
thousand genes were observed to have significantly differentiated expression after IL4 and
anti-CD40 stimulation [31]. The significantly differentiated genes can be formed in 4 cluster
groups including 13 temporal profiles. Each cluster contains many new genes that were not
known to have roles in CSR before.
3.1. Cluster A group
Cluster A group represented the gene expression on (Cluster A1) or off (Cluster A2) in naïve
human B cells after IL4 and anti-CD40 stimulation.
3.1.1. Cluster A1
Cluster A1 was immediately upregulated after IL4 and anti-CD40 cosignal stimulation and the
expressions did not change during the course of 12 days for the experiments. The cluster
contains 153 genes. The analysis of transcription factor–binding sites for the cluster showed
that genes from this cluster were enriched to transcription factors BACH1 and BACH2.
BACH1 and BACH2 promote B cell development by repressing the myeloid program [32].
They belong to the basic region–leucine zipper family and are transcription repressors binding
to Maf-recognition elements (MAREs) [33]. BACH2 has critical roles in both acquired immu-
nity and innate immunity, including immunoglobulin CSR, the somatic hypermutation of
immunoglobulin-encoding genes [34, 35]. BACH2 expression is activated by E2A, Foxo1 and
Pax5 in pro-B cells. BACH2 may have a role in early B cell development [36]. BACH1 structure
is closely related to BACH2, but its role in B cell development and hematopoiesis largely
remains unclear [33]. BACH2 expression frequently preceded that of Ebf1 and Pax5 in the
common lymphoid progenitors (CLPs). BACH factors directly repressed various myeloid
genes in CLPs and this repression restricted the fate of CLPs to the B cell lineage [32].
In this cluster, chemokine genes CCL22 and CCL17 were the most significantly differentiated
genes during naïve B cell activation after IL4 and anti-CD40 signal stimulation. CCL22 and
CCL17 are both ligands for the chemokine receptor CCR4. CCR4 gene was also showed in
Cluster C6 to have a transient induction after IL4 and anti-CD40 signal stimulation. All three
transcripts were within the top 20 differentially expressed genes during the activation of
immunoglobulin class switching in human activated B cells. CCL22 and CCL17 are NF-kappa
B (NF-kB) target genes, indicating a central role for the NF-kB pathway in the activation of CSR
stimulated by IL4 and anti-CD40. The top differentially expressed genes also contained
another NF-kB target gene, the TNF receptor-associated factor (TRAF1) [37], which was also
profiled in Cluster A1. There were many clinical reports that indicated both chemokines might
be involved in human immunoglobulin class switching. A significantly higher increase in
CCL17, CCL22 and IL-4 serum levels in grass pollen–exposed subjects was observed [38].
Sensitized children with allergic symptoms showed higher CCL17 and CCL22 levels and
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higher ratios between these Th2-associated chemokines and the Th1-associated chemokine
CXCL10 than nonsensitized children without allergic symptoms [39]. Using human dendritic
cells (DCs), in vitro exposure to house dust mite (HDM) of DCs from HDM-allergic patients
but not healthy controls caused CCL17 and CCL22 release that resulted in chemoattraction of
polarized human Th2 cells in a CCR4-dependent way [40]. Both CCL22 and CCL17 have been
suggested as biomarkers for disease activity in atopic dermatitis (AD), and raised cord blood
(CB) levels of CCL22 predict subsequent allergic sensitization, while raised CCL17 in GC
predicts the later development of allergic symptoms, including asthma. Consistent with these
observations, allergen exposure in sensitized individuals leads to a dynamic increase in CCL17
and CCL22 [38]. High-affinity neutral ligands have been developed for CCL22 and CCL17 and
attenuate levels of CCL22, CCL17 and IgE in a mouse model of atopic dermatitis as well as
improve skin inflammatory symptoms [31]. CCL17 was also shown to have exon retention
during B cell activation [31]. All the evidence indicated both chemokines and their receptor
CCR4 play important roles in immunoglobulin class switching.
3.1.2. Cluster A2
Cluster A2was immediately downregulated after IL4 and anti-CD40 cosignal stimulation and the
expressions did not change during the course of 12 days of CSR. Cluster A2 contains 83 genes that
present downregulating genes during B cell activation. These genes expressed significantly lower
in activated B cells than in naïve B cells during the time course of IL4 and anti-CD40 stimulation.
The analysis of gene ontology indicated the genes in this cluster were involved with immune
system process.
FOSB and FOS were the most significantly downregulated genes in Cluster A2 during CSR in
naïve B cells after IL4 and anti-CD40 stimulation. FOS genes encode leucine zipper proteins that
can dimerize with proteins of the JUN family and form transcription factor complex activating
protein-1 (AP-1) [41]. The FOS family consists of 4 members: FOS, FOSB, FOSL1 and FOSL2.
Activating protein-1 (AP-1) is a dimeric transcription factor composed of Jun, FOS or activating
transcription factor (ATF) subunits that bind to a common DNA site, the AP-1–binding site [42].
The different AP-1 factors may regulate different target genes and thus execute distinct biological
functions [43]. In addition to regulation by heterodimerization among Jun, FOS and ATF pro-
teins, AP-1 activity is regulated through interactions with specific protein kinases and a variety
of transcriptional coactivators [44–46]. Nitrogen oxide (NO) is the radical inhibiting IgE/Ag-
induced IL-4, IL-6 and TNF production. It inhibits phosphorylation of phospholipase Cγ1 and
the AP-1 transcription factor protein c-Jun. NO further completely abrogated IgE/Ag-induced
DNA-binding activity of the nuclear AP-1 proteins FOS and Jun to regulate allergic inflamma-
tion [47]. FOS-interacting protein (FIP) is a transcription factor that binds to c-FOS. The aggrega-
tion of the mast cell’s high-affinity receptor for IgE induced the synthesis of FIP and increased its
DNA-binding activity. Moreover, downregulation of the isoenzyme protein kinase C-β (PKC-β)
resulted in profound inhibition of FIP-FOS DNA-binding activity [48].
3.2. Cluster B group
Cluster B group showed gradually sustained induction during CSR in B cells. Cluster B1 is the
most interesting cluster that sustained induction earlier than Cluster B2.
Gene Expression during the Activation of Human B Cells
http://dx.doi.org/10.5772/intechopen.71863
169
3.2.1. Cluster B1
Cluster B1 was the first group to show gradually sustained expression after IL4 and anti-CD40
cosignal stimulation. Cluster B1 contains 126 genes and the analysis of gene ontology showed
that genes in this cluster were majorly involved in the cellular amine metabolic process. The
analysis of transcription factor–binding sites indicated the genes in this cluster were enriched
to transcription factors RSRFC4 and STAT. Both transcription factors were involved with
allergic and airway epithelia inflammations [49, 50]. RSRF-binding sites were found in the
regulatory sequences of a number of growth factor–inducible and muscle-specific genes [51]. It
was showed that engagement of the B cell antigen receptor could activate STAT through Lyn
in a JAK-independent pathway [52].
There were several well-known genes to regulate B cell differentiation in germinal center includ-
ing AICDA [24], IRF4 [53], XBP1 [54], BATF3 [55] and NFIL3 [56] in this cluster. The cluster
showed other genes exhibiting synchronic, coordinated expression with the well-documented
regulation genes. IL17RB and BHLHE40 genes were the most significantly differentiated in the
cluster. IL17RB encodes a cytokine receptor that specifically binds to IL17B and IL17E but does
not bind to IL17 and IL17C. IL17RB has been shown to mediate the activation of NF-κB [57].
IL17RB showed highly synchronic expression with AICDA in the cluster. IL17RB abundance has
previously been shown to increase upon allergen challenge in patients with seasonal allergic
rhinitis [58], IgE [59] and asthma [60]. The result indicated that the increase in IL17RB formed an
early component of the transcriptional cascade that initiated the germinal center response in B
cells. BHLHE40 encodes a basic helix-loop-helix protein expressed in various tissues and is an
environmentally inducible moderator of circadian rhythms and cellular differentiation.
BHLHE40 was profiled at its core of the B1 Cluster. BHLHE40 was recently shown to operate as
a master regulator of germinal center activities, modulating the expression of more than 100
target genes [61]. Circadian oscillations in symptom severity are a prominent feature of atopic
diseases including atopic dermatitis, asthma, chronic urticarial and allergic rhinitis [62–64]. The
variation in IgE/mast cell allergic reactions was recently demonstrated to depend on the circa-
dian clock in mice [65]. Mice deficient for the BHLHE40 ortholog display a variety of immune
features including abnormal IgG1 and IgE levels and defective elimination of activated B cells, as
well as exhibiting circadian rhythm phenomena [66]. Like BHLHE40, NFIL3 in this cluster also
participates in signaling pathways relating to the circadian clock [67], and together, these data
suggest there may be a circadian component to class switch recombination and that this may be
of relevance to time-of-day phenomena in IgE-driven diseases.
3.2.2. Cluster B2
The genes in Cluster B2 were also gradually sustained induction but they come later in time
than Cluster B1 during CSR in human B cell. The cluster contains 112 genes. The most
significantly differentiated genes were EPHB1 and TNFSF4.
Erythropoietin-producing hepatocellular carcinoma (Eph) receptors are a subfamily of recep-
tor tyrosine kinases (RTKs) [68, 69]. The receptors and their ligands, the ephrins, mediate
numerous developmental processes, particularly in the nervous system [70]. Tyrosine phos-
phorylation of EphB1 requires presentation of ephrin-B1 in either clustered or membrane-
attached forms [71]. Eph receptors and ephrin ligands have been shown to be differentially
expressed on leucocytes. Ephrin-B3 binds to B lymphocytes, most likely via a nonclassical
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receptor, and induces migration of the memory B cell subpopulation [72]. NFSF4 encodes a
cytokine of the tumor necrosis factor (TNF) ligand family. The encoded protein functions in T
cell and antigen-presenting cell (APC) interact and mediate adhesion of activated T cells to
endothelial cells. The tumor necrosis factor ligand superfamily member 4 gene (TNFSF4,
OX40L), which encodes for the costimulatory molecule OX40 ligand, has been identified as a
susceptibility gene for systemic lupus erythematosus (SLE) in multiple studies [73, 74].
3.3. Cluster C group
Cluster C group has six profiling clusters to show transient induction during CSR in B cells
according to the time they were inducted.
3.3.1. Cluster C1
Cluster C1 was the first group to be inducted transcendently during CSR. It has 79 genes and
the analysis of gene ontology indicated the genes in this cluster were involved in ribonucleo-
protein complex biogenesis. Heterogeneous nuclear ribonucleoproteins (hnRNPs) are a large
family of RNA-binding proteins that are important for multiple aspects of nucleic acid metab-
olism [75]. TFEC and RRP12 were the most significantly introduced genes in this cluster.
Transcription factor EC (TFEC) acts as a repressor or an activator. TFEC works as a transcrip-
tional repressor on minimal promoter containing element F in an E-box sequence-specific man-
ner [76]. It can act as a transcriptional transactivator on the proximal promoter region of the
tartrate-resistant acid phosphatase (TRAP) E-box containing promoter. It also acts as a transcrip-
tional repressor on minimal promoter containing mu E3 enhancer sequence [77]. Gain-of-func-
tion assays indicated that TFEC was capable of expanding hematopoietic stem cells–derived
hematopoiesis. TFEC mutants were showed to reduce hematopoiesis in the caudal hematopoi-
etic tissue, leading to anemia. It mediated these changes by increasing the expression of several
cytokines in caudal endothelial cells [78]. Ribosomal RNA Processing 12 Homolog (RRP12) is a
protein that may have a function to bind to poly(A) RNA. Rrp12 and the exportin Crm1
participate in late assembly events in the nucleolus during 40S ribosomal subunit biogenesis
[79], but there is little knowledge of TFEC and RR12 regulating B cell growth.
3.3.2. Cluster C2
Cluster C2 was the second group to be inducted transcendently during CSR in human B cells
and this cluster contains 112 genes. LMNB2 and B4GALT5 were the most significantly intro-
duced in this cluster.
LMNB2 encodes a B-type nuclear lamin. The nuclear lamina consists of a two-dimensional
matrix of proteins located next to the inner nuclear membrane. Lamin proteins are thought to
be involved in nuclear stability, chromatin structure and gene expression. B-type lamins play a
role in DNA replication, the formation of the mitotic spindle, chromatin organization and
regulation of gene expression [80]. B4GALT5 encodes one of seven beta-1,4-galactosyltransferase.
It is the type II membrane-bound glycoproteins that appear to have exclusive specificity for the
donor substrate UDP-galactose; B4GALT5 was found to have a change in a statin-induced
experiment in gene expression in EBV-transformed and native B cells [81].
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3.3.3. Cluster C3
Cluster C3 was the third group to be inducted transcendently during CSR in B cells and the cluster
has 105 genes. The analysis of gene ontology indicated the genes in this cluster were involved with
DNAmetabolic process.UHRF1 and CHEK1were the most significantly introduced in this group.
UHRF1 gene encodes a member of a subfamily of RING-finger–type E3 ubiquitin ligases. The
protein binds to specific DNA sequences and recruits a histone deacetylase to regulate gene
expression. Its expression peaks at late G1 phase and continues during G2 and M phases of the
cell cycle. Colonization of germ-free mice with gut microbiota showed increasing expression of
Uhrf1 in Treg cells. Uhrf1 deficiency resulted in de-repression of the gene (Cdkn1a) [77]. CHEK1
encodes a protein belonging to the Ser/Thr protein kinase family. It is required for checkpoint-
mediated cell cycle arrest in response to DNA damage or the presence of unreplicated DNA.
Activated CHEK1 can phosphorylate and modulate the activity of a number of proteins includ-
ing p53, providing a link between sensing of DNA damage and p53 checkpoint activity. BCL6
can directly bind to a DNA consensus element in the CHEK1 promoter and repress its expression
in normal and malignant B cell [82].
3.3.4. Cluster C4
Cluster C4 was the fourth group to be inducted transcendently during CSR and it has 151 genes.
The analysis of gene ontology showed that the genes in this cluster were majorly involved in the
M phase. The analysis of transcription factor enrichment indicated the genes in this cluster were
enriched to nuclear transcription factor Y (NF-Y). NF-Y in eukaryotes consists of three different
subunits, NF-YA, NF-YB and NF-YC, which are all necessary for the formation of NF-Y com-
plexes and binding to CCAAT boxes in promoters of their target genes. Recent studies demon-
strated novel contributions of NF-Y to apoptosis and apoptosis-induced proliferation and in
photoreceptor cell differentiation during the development of the Drosophila compound eye [83].
KIF14 and PRC1 were the most significantly differential expression genes in the cluster. KIF14
encodes a member of the kinesin-3 superfamily of microtubule motor proteins. These proteins
are involved in numerous processes including vesicle transport, chromosome segregation,
mitotic spindle formation and cytokinesis. Knockdown of this gene results in failed cytokinesis
with endoreplication. This gene was identified as a likely oncogene in breast, lung and ovarian
cancers, as well as in retinoblastomas and gliomas [84]. Protein regulator of cytokinesis 1
(PRC1) gene is a crucial regulator of cytokinesis [85]. Its suppression may result in mitotic
failure and its involvement in various cancers [86]. PRC1 is a key regulator of cytokinesis that
cross-links antiparallel microtubules. Multiple mitotic kinesins and microtubule-associated
proteins (MAPs) act in concert to direct cytokinesis [87]. The MAP and microtubule-bundling
protein PRC1 is one of the key molecules required for the integrity of this structure. Endoge-
nous PRC1 can be interacted with KIF14. KIF14 targets the central spindle via its interaction
with PRC1 and has an essential function in cytokinesis [88].
3.3.5. Cluster C5
Cluster C5 was the fifth group to be inducted transcendently and it has 99 genes.MCM10 and
PCNA genes were the most differentially expressed in the cluster.
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MCM10 encodes one of the highly conserved mini-chromosome maintenance proteins (MCM)
that are involved in the initiation of eukaryotic genome replication. Human MCM10 regulates
the catalytic subunit of DNA polymerase-α and prevents DNA damage during replication
[89]. MCM10 interacts with RECQ4 (RecQ helicases 4) and is important for efficient replication
[90, 91]. PCNA encodes a cofactor of DNA polymerase delta in nucleus. The protein acts as a
homotrimer and helps increase the processivity of leading strand synthesis during DNA
replication. PCNA was well studied in plants and had the ability to stimulate the activity of
DNA polymerase δ and the ability to interact with p21, a regulator of the cell cycle [92].
3.3.6. Cluster C6
Cluster C6 was the sixth group to be inducted transcendently and it contains 128 genes. CCR4
and HIST1H1C genes were the most differentially expressed in the whole process during naïve
B cell activation with IL4 and anti-CD40 signal stimulation.
CCR4 is the receptor of CCL17 and CCL22. It is later inducted, which means that the three may
work in late stage of CSR. CCR4 was previously detected in nongerminal center cells. The
possible functional roles in CSR were discussed in Section 3.1.1. Histone H1 has previously
been shown to influence mast cell–mediated type-I hyperreactivity in mice [93].
3.4. Cluster D group
Cluster D group has three profiling clusters to show transient downregulation during CSR
according to the time of downregulation.
3.4.1. Cluster D1
Cluster D1 was the first group to be inducted transcendently and it contains 99 genes. GPR18
and TP53INP1 genes were the most differentially expressed in the cluster.
GPR18 encodes G protein–coupled receptor 18. The activity of this receptor is mediated by G
proteins, which inhibit adenylyl cyclase [94], and it contributes to regulation of the immune
system. GPR18 also mediates NAGly-induced process of reorganization of actin filaments
and induction of acrosomal exocytosis. Stimulation of human spermatozoa with the GPR18
ligand N-arachidonoylglycine induced the phosphorylation of 12 protein kinases. N-
arachidonoylglycine affects the cytoskeleton by changing levels of F-actin and inducing the
acrosome reaction in human spermatozoa in a concentration-dependent manner. GPR18
might be involved in physiological processes of human spermatozoa [95]. Tumor protein
53-induced nuclear protein 1 (TP53INP1) is a tumor suppressor. It was described as a p53
target gene involved in cell death, cell-cycle arrest and cellular migration [96]. TP53INP1 is
also able to interact with ATG8-family proteins to induce autophagy-dependent cell death
by caspase-dependent autophagy [97].
3.4.2. Cluster D2
Cluster D2 was the second group to be inducted transcendently during CSR in B cells. It
contains 69 genes. RAB6B and PM20D1 genes were the most differentially expressed.
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RAB6B (RAB6B, member RAS oncogene family) has the ability for GTP binding and myosin V
binding. Members of the RAB subfamily of small GTPases play an important role in the regula-
tion of intracellular transport routes [98]. RAB6B is predominantly expressed in brain and the
neuroblastoma cell line SK-N-SH. In brain, RAB6B was found to be specifically expressed
in microglia, pericytes and Purkinje cells. Endogenous RAB6B localizes to the Golgi apparatus
and to ERGIC-53–positive vesicles. RAB6B displayed lower GTP-binding activities, and in overe-
xpression studies, the protein is distributed over Golgi and ER membranes [99]. A secreted
enzyme, peptidase M20 domain containing 1 (PM20D1), is enriched in UCP1(+) versus UCP1()
adipocytes. These data identify an enzymatic node and a family of metabolites that regulate
energy homeostasis [99].
3.4.3. Cluster D3
Cluster D3 was the third group to be inducted transcendently in CSR of human B
cells and the cluster has 113 genes. IKZF2 and ADCY1 genes were the most differentially
expressed.
IKZF2 encodes a member of the Ikaros family of zinc-finger proteins. Three members of this
protein family (Ikaros, Aiolos and Helios) are hematopoietic-specific transcription factors involv-
ed in the regulation of lymphocyte development. This protein forms homo- or heterodimers with
other Ikaros family members and has a function predominantly in early hematopoietic develop-
ment. Helios is preferentially expressed at the mRNA level by regulatory T cells (Treg cells) and is
potentially a specific marker of thymic-derived Treg cells. It raises the possibility that a significant
percentage of Foxp3+ Treg cells are generated extrathymically [100]. ADCY1 gene encodes a
member of the adenylate cyclase family that is primarily expressed in the brain. This protein is
regulated by calcium/calmodulin concentration. Cyclic AMP (cAMP) production, which is impor-
tant for mechanotransduction within the inner ear, is catalyzed by adenylate cyclases (AC).
ADCY1 has an evolutionarily conserved role in hearing, and cAMP signaling is important to hair
cell function within the inner ear [101].
The most significantly differential genes in each cluster and major pathways in each cluster are
listed in Table 1. The most interesting clusters are Cluster A1 and Cluster B1 and the full gene
names of these two clusters are listed in Tables 2 and 3.
Cluster Numbers Activation
during CSR
Most significant genes Pathways involved References
A1 153 Expression on CCL22; CCL17; TRAF; BCL2L1;
MYB; VIM; TRIP10; FAS; PTGIR;
EBI3; AHR; NCF2
ERK signaling, TRAF
pathway; insulin pathway;
NF-kB pathway
[105–108]
A2 83 Expression off MARCH1; FOSB; DUSP1; FOS;
CR1; CR2; RGS2; PLD4; CCR6;
RASGRP2;MOP-1; FCRLA
Toll-like receptor signaling
pathways, MAPK signaling
pathway; innate immune
system pathway
[109–111]
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Cluster Numbers Activation
during CSR
Most significant genes Pathways involved References
B1 126 Sustained
induction
BHLHE40; IL17RB; NFIL3;
HOMER2; AICDA; BATF3;
ARID5A; DUSP4; CD80;
TNFAIP2; XBP1;MTHFD2
Circadian rhythm pathway;
IL-17 family signaling
pathways; IL4-mediated
signaling pathway
[57, 112, 113]
B2 112 Sustained
induction
EPHB1; TNFSF4; DPYSL2;
RPS6KA2; SLC41A1; AMICA1;
MIIP; RGS9; CISH; LRRC32;
AUH; SLC37A3
EPH-Ephrin signaling; TNF
superfamily pathway;
transport of glucose pathway
[114–116]
C1 79 Transient
induction
TFEC; RRP12; SLC29A1;
GPATCH4; SSRP1; BCL2A1;
CYB561; NME1; TTLL12; FASN;
NETO2; SLC27A4
C-MYB transcription factor
network; apoptosis
modulation and signaling
[117, 118]
C2 112 Transient
induction
LMNB2; B4GALT5; SLC43A3;
ESPL1; EZH2; PSMC3; SUV39H2;
MREG; FSCN1; SRC;
PHOSPHO2-KLHL23
Apoptosis pathway;
glycosaminoglycan
metabolism pathway
[119, 120]
C3 105 Transient
induction
UHRF1; CHEK1; FANCI;
CHAF1B; DTL; CDC6; EXO1;
MCM6; CHAF1A; CDC45; TCF19
Chromatin regulation/
acetylation pathway; DNA
double-strand break repair
pathway
[121, 122]
C4 151 Transient
induction
KIF14; PRC1; NDC80; NUF2;
HMMR; DEPDC1; AURKA;
ARHGAP11B; BRCA1; FAM72B;
HIST1H4L; DLGAP5; HIST1H1B
Signaling by Rho GTPases;
cell cycle pathway; DNA
double-strand break repair
pathway
[85, 123, 124]
C5 99 Transient
induction
MCM10; PCNA; TCFL5; HELLS;
ZC3HAV1L; PHF19; CARM1;
VDR; LIMA1;MYH10; SEMA4A;
TMOD1
Telomere C-strand synthesis
pathway; apoptosis
modulation and signaling;
chromatin regulation/
acetylation
[125–127]
C6 128 Transient
induction
CCR4; HIST1H1C; CHRNA6;
HIST1H3I; CCL1; GPR55; SYT11;
PSTPIP2; KIAA1549L;
HIST1H1D; PSAT1; TFDP2
Signaling by GPCR; apoptosis
induced DNA fragmentation;
nicotine pathway
[128–130]
D1 69 Transient
downregulation
GPR18; TP53INP1; IFIT2;
RNASET2; LBH; DOK3; FGD3;
CD69; OAS1; ABCG1; PNOC;
PARP15
Signaling by GPCR; p53
pathway, innate immune
system; B cell development
pathway
[96, 131–133]
D2 69 Transient
downregulation
RAB6B; PM20D1; CYP2C19;
CPNE4; TNFSF8; HIST1H2BD;
METTL7A; ADHFE1; TMEM140;
JMJD7; KLHL24; POU2AF1
Vesicle-mediated transport;
drug metabolism; ERK
signaling
[134–136]
D3 113 Transient
downregulation
IKZF2; ADCY1; APOBEC3H;
VAMP5; PDCD1LG2; CYP2C18;
ILDR1; ADRB1; TM6SF1;
GCSAM; CHAC1; ENPP3
mRNA editing—C to U
conversion; NF-kB signaling;
cytochrome P450 pathway
[137–139]
Table 1. The most significantly differential genes and pathways in each cluster during CSR.
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Cluster A1: 153 genes
CCL22 CCL17 TRAF1 BCL2L1 MYB VIM TRIP10 FAS PTGIR EBI3
AHR NCF2 BCAT1 MGLL SEMA4C SIRPA TFPI2 ARNTL2 STAT5A HYOU1
ADA ICAM1 CFLAR MYO1C IGSF3 CCR7 SEPT11 WSB2 IL13RA1 CDK2AP1
CLIP2 NFKB2 PGD HIPK2 CD58 MARCKS SNX8 TNFAIP3 TNIP1 SLAMF7
SLC43A2 FADS1 FAM129A RAP2A YWHAG CYFIP1 LOC101929479 GNG8 IRF5 TMEM120A
FCER2 IPO7 CBX6 CDK6 BLVRA AP1S3 XPO5 PIK3R5 LSP1 FNBP1
TAGLN2 RBBP9 SPINT2 FYTTD1 GPR137B PEF1 PPA1 RANGAP1 LSM11 RHOF
WDR91 ATP1A1 MIR17HG SUPT16H USP14 CPNE8 MMP7 EEF2K PPME1 ANXA7
EHD4 CDR2 SRPK1 BLMH UBE2Z KDM2B PPP1R7 CAPRIN1 SF3B6 TALDO1
LMNA MCOLN2 SCD PCGF5 HERPUD1 NFKB1 CHURC1-FNTB ERH TJP2 BSG
VOPP1 KEAP1 CEP85 NAE1 UBTD2 TKT GOT2 SZRD1 APOL1 NSUN4
CHMP4B TRIM28 KCNN4 SLC16A1 SLC9A7 SLC20A1 MAP4 ZNF48 ECE1 ADCY3
STX11 LARP4 OTUD7B GPR183 PSMD8 ZAK SLC35F2 COA7 ANXA5 IDE
SLC39A1 MDFIC GSTP1 OGFOD1 SEC23B IMPDH2 HDLBP HTT KIF13B GTF3C4
ACSL4 MPC1 PITPNB TNIP2 EXOC3 MDH1 PLEKHA7 UBE2D4 JADE3 POR
PEA15 PIK3CD TP53BP2
Table 2. The lists of Cluster A1.
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4. The future research on CSR in human B cells
A total of 1399 genes were shown to have differential expression during CSR in human B cells,
and the novel genes have the roles in immune system process, cellular amine and DNA
process and cell cycle phase or ribonucleoprotein biogenesis. Understanding the precisely
functional roles of these novel genes in CSR in human B cells will bring new insights into the
mechanisms of CSR and find potential therapeutic targets for human immune disorders such
as allergic asthma and autoimmune diseases.
The next stage of research will also focus on determining how the naïve B cells turn into the
specific IgE-, IgA- or IgG-releasing cells after T cell cytokines signal stimulation. The different
stages of CSR in human B cell may contain unique transcription regulators for the destiny for
each single cell. The development of single-cell sequencing provides a unique opportunity to
explore the subsets of the human B cells to generate IgE, IgA and IgG. Obtaining high-quality
single-cell sequencing data from B cells depends on efficient isolation of individual cells and
amplifications of the genome or transcriptome of single cell to acquire sufficient materials for
downstream analysis, identifying true variations from technological biases [102]. One of the
major challenges of analyzing single-cell genomics data is to develop tools that differentiate
technical artifacts and noise introduced during single-cell isolation, whole genome amplifica-
tion, whole transcriptome amplification and sequencing from true biological variation. There
are many factors that can influence the single-cell analysis. During single-cell isolation, the
population of cells can be biased through the selection of cells based on size, viability or
propensity to enter the cell cycle. Cells from cell lines as control may be problematic as they
Cluster B1: 126 genes
BHLHE40 IL17RB NFIL3 HOMER2 AICDA BATF3 ARID5A DUSP4 CD80 TNFAIP2
XBP1 MTHFD2 CD86 CD59 CAMK4 MFHAS1 SLC1A5 SRGN USP46 CHDH
HDGFR3 PIGX FLT1 RNF19B LTA NOD2 ZNF788 AARS ATXN1 RFC5
WARS PXDC1 PPP1R14A DENND5A QSOX1 STK38L PRR5L RGS10 SLC7A5 SCCPDH
RRAGD LY75-
CD302
ADAMDEC1 YARS GPHN TRIM16L IRF4 NINJ1 SLC7A1 SOCS1
CD274 ECHDC3 NECAP2 TSPAN33 SEC11C LOXL3 AHRR RALB ARID3A RDX
CSF1 THG1L SLC39A8 SAMSN1 TXNL1 STK35 DARS TARS CLDND1 C12orf5
SEL1L CARS FAM162A VCL SEPHS1 XPOT ACSL1 GOT1 PFKM NSMCE1
RBM47 CEP19 ATXN2L DHRS3 RAB39B DCTN2 PABPC4 HIVEP1 CCDC126 ACADVL
MTX2 AEN TFG RBPJ SLC25A20 ETFDH COPA NR4A3 GPX4 ITFG3
DUSP22 CTNS IL2RA RAP1A TNFAIP1 PAM SLC37A1 DCTN6 AKAP2 RIPK2
RAB21 RPS23 KIAA1279 MARS ZNF267 CLCN5 NFKBID PRPSAP1 NEDD1 ZNF382
CDKN1A PRRT3 LYSMD1 NCK2 AZIN1 KIF5B
Table 3. The lists of Cluster B1.
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may not be diploid, and they can be highly aneuploid or even polyploidy. These will affect
experimental performance [102]. Our understanding of human B cell function in CSR will
derive from comparisons between healthy individuals and those with particular immunolog-
ical diseases, and among groups of patients having the same disease with different clinical
outcomes. For example, human SLE is clinically heterogeneous [103], making treatment deci-
sion challenging. It is important to know which B cell subsets are responsible for which
functions in immune diseases, in addition to identifying how a “signature” profile for an
individual subject’s collection of subsets may correlate with disease outcome that could even-
tually allow greater optimization of targeted therapies [104].
Abbreviation
AC adenylate cyclases
AID activation-induced cytidine deaminase
AP-1 activating protein-1
APC antigen-presenting cell
APE apurinic/apyrimidic endonuclease
BCRs B cell receptors
Be-1 B effector 1
Be-2 B effector 2
CB cord blood
CLPs common lymphoid progenitors
CSR class switch recombination
DCs dendritic cells
DSBs double-strand DNA breaks
Eph erythropoietin-producing hepatocellular
FIP FOS-interacting protein
FO follicular
GCs germinal centers
HDM house dust mite
hnRNPs heterogeneous nuclear ribonucleoproteins
IgH Ig heavy-chain
MAPs microtubule-associated proteins
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MAREs Maf-recognition elements
MCM mini-chromosome maintenance proteins
MZ marginal zone
NF-kB NF-kappa B
NHEJ nonhomologous end-joining
NO nitrogen oxide
PKC-β protein kinase C-β
PRC1 protein regulator of cytokinesis 1
RAG recombination activating gene
RTKs receptor tyrosine kinases
SLE systemic lupus erythematosus
TD T lymphocyte dependent
TFEC transcription factor EC
TI T lymphocyte independent
TNF tumor necrosis factor
TRAF TNF receptor associated factor
TRAP tartrate-resistant acid phosphatase
UNG uracil DNA glycosylase
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